Pharmacokinetics and pharmacodynamics in the elderly

Clinical Advances in Hematology and Oncology

Volumn 5, Issue 3, 2007, Pages 181-182

  Lichtman, Stuart M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CYTARABINE; DOCETAXEL; ERLOTINIB; FLUOROPYRIMIDINE; HEMOPOIETIC GROWTH FACTOR; METHOTREXATE; PACLITAXEL; TOPOTECAN; TRASTUZUMAB;

ABSENCE OF SIDE EFFECTS; AREA UNDER THE CURVE; ARTICLE; BONE MARROW SUPPRESSION; CANCER; CARDIOTOXICITY; COLORECTAL CANCER; CREATININE BLOOD LEVEL; DIARRHEA; DOSE KIDNEY FUNCTION RELATION; DRUG EFFICACY; ELDERLY CARE; FOOD AND DRUG ADMINISTRATION; GERIATRIC ASSESSMENT; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MUCOSA INFLAMMATION; PATIENT ASSESSMENT; POLYPHARMACY; RASH;

AGED; ANTINEOPLASTIC AGENTS; DRUG INTERACTIONS; HUMANS; KIDNEY FUNCTION TESTS; NEOPLASMS; RESEARCH;

EID: 34247463778     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hurria A, Lichtman SM. Pharmacokinetics of chemotherapy in the older patient. Cancer Control. 2007;14:32-43.
2. Lichtman SM, Wildiers H, Launay-Vacher V, Steer C, Chatelut E, Aapro M. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer parients with renal insufficiency. Eur J Cancer. 2007 Jan;43:14-34.
3. Lichtman SM, Hollis D, Miller AA, et al; Cancer and Leukemia Group B (CALGB 9762). Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762).J Clin Oncol. 2006;24:1846-1851.
4. Lichtman SM. Therapy insight: Therapeutic challenges in the treatment of elderly cancer patients. Nat Clin Pract Oncol. 2006;3:86-93.
5. Lichtman SM. Chemotherapy in the elderly. Semin Oncol. 2004;31:160-174.
6. Wasil T, Lichtman SM. Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly. Oncologist. 2005;10:602-612.